Published in World J Gastroenterol on October 15, 2004
Hepatitis B virus S gene escape mutants. Asian J Transfus Sci (2007) 1.14
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (1989) 23.74
Global control of hepatitis B virus infection. Lancet Infect Dis (2002) 3.74
Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci (2001) 1.61
Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology (2001) 1.61
Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology (1997) 1.58
Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol (1994) 1.43
In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J Immunol (2000) 1.17
Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology (2002) 1.10
Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene. Med Sci Monit (2001) 1.09
A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol (1994) 1.07
Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission. Virus Res (2002) 1.00
Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. Clin Lab (2004) 0.99
Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees. J Gastroenterol Hepatol (2001) 0.98
Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy. J Med Virol (2003) 0.98
Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies. J Med Virol (2001) 0.97
Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc. J Gastroenterol Hepatol (2002) 0.89
Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination. J Immunol (1997) 0.88
Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV-related chronic liver disease patients. J Med Virol (2003) 0.87
Acute self-limiting hepatitis B after immunoprophylaxis failure in an infant. J Med Virol (2002) 0.86
Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus. J Gastroenterol (2003) 0.86
Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid. Vaccine (1999) 0.86
A 'first loop' linear epitope accessible on native hepatitis B surface antigen that persists in the face of 'second loop' immune escape. J Gen Virol (2003) 0.84
Molecular analysis of the a determinant of HBsAg in children of HBeAg-positive mothers upon failure of postexposure prophylaxis. Int J Infect Dis (1998) 0.83
Global control of primary hepatocellular carcinoma with hepatitis B vaccine: the contributions of research in Taiwan. Cancer Epidemiol Biomarkers Prev (2003) 0.82
At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis. Res Virol (1998) 0.82
A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene. World J Gastroenterol (2003) 0.81
Assessment of current epidemiological status of viral hepatitis in Guangdong Province, China. Southeast Asian J Trop Med Public Health (2002) 0.81
Peptide analogues of a subdominant epitope expressed in ebv-associated tumors: synthesis and immunological activity. J Med Chem (2001) 0.78
Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus. J Virol (2001) 0.78
The detection of recombinant hepatitis B surface antigen from "vaccine escape mutants" in two HBsAg immunoassays. Clin Lab (2000) 0.77
Prevention and therapy of hepatitis B. Chin Med J (Engl) (1999) 0.77
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J Infect Dis (2006) 5.53
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial. J Clin Oncol (2012) 2.76
Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer. J Clin Oncol (2007) 2.69
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol (2008) 2.40
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial. Clin Vaccine Immunol (2006) 2.39
Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. Am J Epidemiol (2005) 1.83
Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials. J Immunol Methods (2006) 1.76
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals. Vaccine (2006) 1.71
Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial. Am Heart J (2003) 1.65
Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China. J Gastroenterol (2006) 1.60
Direct atomic-scale confirmation of three-phase storage mechanism in Li₄Ti₅O₁₂ anodes for room-temperature sodium-ion batteries. Nat Commun (2013) 1.41
Smaller sulfur molecules promise better lithium-sulfur batteries. J Am Chem Soc (2012) 1.38
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. J Thorac Oncol (2010) 1.34
Reversible storage of lithium in silver-coated three-dimensional macroporous silicon. Adv Mater (2010) 1.32
Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Res Treat (2008) 1.28
Atom-resolved imaging of ordered defect superstructures at individual grain boundaries. Nature (2011) 1.26
Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg (2014) 1.26
A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest (2008) 1.26
Synthesis of nitrogen-doped MnO/graphene nanosheets hybrid material for lithium ion batteries. ACS Appl Mater Interfaces (2012) 1.25
Enhanced capacitance of manganese oxide via confinement inside carbon nanotubes. Chem Commun (Camb) (2010) 1.17
Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol (2009) 1.12
MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract (2013) 1.12
Risk factors for primary liver carcinoma in Chinese population. World J Gastroenterol (2005) 1.05
Evidence for a crucial role played by oxygen vacancies in LaMnO3 resistive switching memories. Small (2012) 1.04
Interfacial effects in iron-nickel hydroxide-platinum nanoparticles enhance catalytic oxidation. Science (2014) 1.03
Codon 249 mutations of p53 gene in development of hepatocellular carcinoma. World J Gastroenterol (1998) 1.02
Rutile-TiO2 nanocoating for a high-rate Li4Ti5O12 anode of a lithium-ion battery. J Am Chem Soc (2012) 1.01
Ultrahigh energy density of polymer nanocomposites containing BaTiO3@TiO2 nanofibers by atomic-scale interface engineering. Adv Mater (2014) 1.00
Lithium storage in Li4Ti5O12 spinel: the full static picture from electron microscopy. Adv Mater (2012) 0.99
Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Hepatobiliary Pancreat Dis Int (2003) 0.99
Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: a comparative study. Cell Biol Int (2008) 0.97
Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroenterol Hepatol (2013) 0.97
Randomized phase II trial of docetaxel plus cetuximab or docetaxel plus bortezomib in patients with advanced non-small-cell lung cancer and a performance status of 2: CALGB 30402. J Clin Oncol (2009) 0.95
Optimal management of malignant pleural effusions (results of CALGB 30102). J Natl Compr Canc Netw (2012) 0.95
CuO nanosheets/rGO hybrid lamellar films with enhanced capacitance. Nanoscale (2013) 0.93
Low-temperature ionic-liquid-based synthesis of nanostructured iron-based fluoride cathodes for lithium batteries. Adv Mater (2010) 0.92
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107). Lung Cancer (2011) 0.92
Downregulation of miR-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis. Int J Mol Med (2013) 0.91
Elimination of photon quenching by a transition layer to fabricate a quenching-shield sandwich structure for 800 nm excited upconversion luminescence of Nd3+-sensitized nanoparticles. Adv Mater (2013) 0.91
Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection. Liver Int (2006) 0.90
Codon 249 mutations of p53 gene in non-neoplastic liver tissues. World J Gastroenterol (1999) 0.89
Encapsulation of Sn@carbon nanoparticles in bamboo-like hollow carbon nanofibers as an anode material in lithium-based batteries. Angew Chem Int Ed Engl (2009) 0.89
Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. J Thorac Oncol (2009) 0.89
Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer. Genes Cancer (2011) 0.89
Solution-processable, low-voltage, and high-performance monolayer field-effect transistors with aqueous stability and high sensitivity. Adv Mater (2015) 0.89
Highly ordered staging structural interface between LiFePO4 and FePO4. Phys Chem Chem Phys (2012) 0.88
Germanium nanoparticles encapsulated in flexible carbon nanofibers as self-supported electrodes for high performance lithium-ion batteries. Nanoscale (2014) 0.88
Mesoporous NiCo(2)O(4) nanoflakes as electrocatalysts for rechargeable Li-O(2) batteries. Chem Commun (Camb) (2013) 0.88
Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105. Int J Radiat Oncol Biol Phys (2011) 0.88
Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro. Cell Biol Int (2009) 0.88
Li storage in 3D nanoporous Au-supported nanocrystalline tin. Adv Mater (2011) 0.88
High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV. Liver Int (2013) 0.88
High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter. World J Gastroenterol (2005) 0.87
Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803. J Thorac Cardiovasc Surg (2013) 0.86
Effect of revaccination using different schemes among adults with low or undetectable anti-HBs titers after hepatitis B virus vaccination. Clin Vaccine Immunol (2010) 0.86
Flexible CuO nanosheets/reduced-graphene oxide composite paper: binder-free anode for high-performance lithium-ion batteries. ACS Appl Mater Interfaces (2013) 0.86
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients' persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer. Breast Cancer Res Treat (2012) 0.85
Electrospinning of highly electroactive carbon-coated single-crystalline LiFePO4 nanowires. Angew Chem Int Ed Engl (2011) 0.85
Direct observation of multiferroic vortex domains in YMnO3. Sci Rep (2013) 0.85
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). J Thorac Oncol (2008) 0.85
Acidification induces Bax translocation to the mitochondria and promotes ultraviolet light-induced apoptosis. Cell Mol Biol Lett (2007) 0.85
An ultrastable anode for long-life room-temperature sodium-ion batteries. Angew Chem Int Ed Engl (2014) 0.85
[Clinical features and prognosis of 25 cases of breast carcinosarcoma]. Zhonghua Zhong Liu Za Zhi (2012) 0.85
Tin nanoparticles encapsulated in porous multichannel carbon microtubes: preparation by single-nozzle electrospinning and application as anode material for high-performance Li-based batteries. J Am Chem Soc (2009) 0.85
Free-standing and binder-free sodium-ion electrodes with ultralong cycle life and high rate performance based on porous carbon nanofibers. Nanoscale (2014) 0.85
Rare inborn errors associated with chronic hepatitis B virus infection. Hepatology (2012) 0.84
Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633. J Thorac Oncol (2010) 0.84
Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure. PLoS One (2012) 0.84
Facile preparation of mesoporous titanium nitride microspheres for electrochemical energy storage. ACS Appl Mater Interfaces (2010) 0.84
A panel of 16 full-length HCV genomes was characterized in China belonging to genotypes 1-6 including subtype 2f and two novel genotype 6 variants. Infect Genet Evol (2013) 0.83
Carbon nanotube wiring of electrodes for high-rate lithium batteries using an imidazolium-based ionic liquid precursor as dispersant and binder: a case study on iron fluoride nanoparticles. ACS Nano (2011) 0.83
New insight into the atomic structure of electrochemically delithiated O3-Li(₁-x)CoO₂ (0 ≤ x ≤ 0.5) nanoparticles. Nano Lett (2012) 0.83
[Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients]. Zhonghua Gan Zang Bing Za Zhi (2006) 0.82
Coaxial Ni(x)Co(2x)(OH)(6x)/TiN nanotube arrays as supercapacitor electrodes. ACS Nano (2013) 0.82
[Status of hepatitis C in Guangzhou from 2005 to 2008]. Zhonghua Gan Zang Bing Za Zhi (2010) 0.81
Mesoporous coaxial titanium nitride-vanadium nitride fibers of core-shell structures for high-performance supercapacitors. ACS Appl Mater Interfaces (2011) 0.81
Expanding micelle nanolithography to the self-assembly of multicomponent core-shell nanoparticles. J Am Chem Soc (2010) 0.81
Relationship between the genetic variation in interleukin 28B and response to antiviral therapy in patients with chronic hepatitis C. Chin Med J (Engl) (2012) 0.81
Venous diethylene glycol poisoning in patients with preexisting severe liver disease in China. World J Gastroenterol (2008) 0.81
Interfacial-strain-induced structural and polarization evolutions in epitaxial multiferroic BiFeO3 (001) thin films. ACS Appl Mater Interfaces (2015) 0.81
Highly reversible lithium storage in Si (core)-hollow carbon nanofibers (sheath) nanocomposites. Nanoscale (2013) 0.80
Correlation between evolution of resistive switching and oxygen vacancy configuration in La₀.₅Ca₀.₅MnO₃ based memristive devices. Nanotechnology (2012) 0.80
An FeF(3)·0.5H2O polytype: a microporous framework compound with intersecting tunnels for Li and Na batteries. J Am Chem Soc (2013) 0.80
Electrochemical treatment of anionic surfactants in synthetic wastewater with three-dimensional electrodes. J Hazard Mater (2006) 0.80
Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004). Lung Cancer (2005) 0.80
Metal-catalyzed growth of semiconductor nanostructures without solubility and diffusivity constraints. Adv Mater (2010) 0.80
A case of arrythmogenic right ventricular cardiomyopathy in a middle-aged woman. J Cardiovasc Dis Res (2011) 0.80
NiCo2S4 sub-micron spheres: an efficient non-precious metal bifunctional electrocatalyst. Nanoscale (2014) 0.80
Molybdenum nitride based hybrid cathode for rechargeable lithium-O2 batteries. Chem Commun (Camb) (2011) 0.79
Decline of serum HBV DNA and no change apportioned by the same hepatic parenchyma cell volume from hepatic fibrosis stage 1 to stage 4 during the natural history of chronic hepatitis B. Intervirology (2008) 0.79
Expression level of novel tumor suppressor gene FATS is associated with the outcome of node positive breast cancer. Chin Med J (Engl) (2011) 0.79
What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients? World J Gastroenterol (2012) 0.79
Liver myofibroblasts regulate the phenotype and function of monocytes through soluble factors in cirrhosis. Exp Ther Med (2012) 0.79